ZA200808872B - Recombinant attenuated clostridium organisms and vaccine - Google Patents

Recombinant attenuated clostridium organisms and vaccine

Info

Publication number
ZA200808872B
ZA200808872B ZA200808872A ZA200808872A ZA200808872B ZA 200808872 B ZA200808872 B ZA 200808872B ZA 200808872 A ZA200808872 A ZA 200808872A ZA 200808872 A ZA200808872 A ZA 200808872A ZA 200808872 B ZA200808872 B ZA 200808872B
Authority
ZA
South Africa
Prior art keywords
vaccine
recombinant attenuated
attenuated clostridium
clostridium organisms
organisms
Prior art date
Application number
ZA200808872A
Other languages
English (en)
Inventor
Mark D Cochran
Petersen Gary
Steven V Lair
Synenki Richard
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of ZA200808872B publication Critical patent/ZA200808872B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
ZA200808872A 2006-04-17 2008-10-16 Recombinant attenuated clostridium organisms and vaccine ZA200808872B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79255306P 2006-04-17 2006-04-17

Publications (1)

Publication Number Publication Date
ZA200808872B true ZA200808872B (en) 2009-11-25

Family

ID=38625523

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200808872A ZA200808872B (en) 2006-04-17 2008-10-16 Recombinant attenuated clostridium organisms and vaccine

Country Status (24)

Country Link
US (3) US7732187B2 (xx)
EP (2) EP2368571A1 (xx)
JP (2) JP5551933B2 (xx)
KR (1) KR20080110908A (xx)
CN (1) CN101489584B (xx)
AR (2) AR060471A1 (xx)
AU (1) AU2007240949B2 (xx)
BR (1) BRPI0711572A2 (xx)
CA (1) CA2649426C (xx)
CO (1) CO6140037A2 (xx)
EC (1) ECSP088827A (xx)
ES (1) ES2401810T3 (xx)
HK (1) HK1125315A1 (xx)
IL (1) IL194714A (xx)
MX (1) MX2008013451A (xx)
NO (1) NO20084810L (xx)
NZ (1) NZ571970A (xx)
PE (1) PE20080167A1 (xx)
PL (1) PL2007420T3 (xx)
RU (2) RU2593945C2 (xx)
TW (1) TWI338045B (xx)
UA (2) UA109105C2 (xx)
WO (1) WO2007123850A2 (xx)
ZA (1) ZA200808872B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US20060083750A1 (en) * 1999-11-19 2006-04-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
BRPI0912703A2 (pt) * 2008-04-29 2017-06-13 Immunexcite Inc composições imuno-moduladoras e métodos para uso dessas
CA2811056A1 (en) * 2010-09-10 2012-03-15 Viropharma Incorporated Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
GEP201706766B (en) 2011-07-22 2017-10-25 Los Angeles Biomedical Res Center Methods and compositions for vaccinating against staphylococcus aureus
RU2017127772A (ru) * 2012-03-02 2019-02-04 Регенерон Фармасьютикалз, Инк. Человеческие антитела к токсинам clostridium difficile
RU2679039C2 (ru) 2012-10-26 2019-02-05 Интервет Интернэшнл Б.В. Вызывающие перекрестный иммунитет вакцины против сальмонеллы
WO2014144211A2 (en) 2013-03-15 2014-09-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
EP3426287A4 (en) 2016-03-09 2020-03-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center METHODS AND KITS FOR USE IN THE PREVENTION AND TREATMENT OF VULVO-VAGINAL CANDIDOSIS
CN109602898B (zh) * 2018-12-28 2022-02-22 江苏省农业科学院 一种产气荚膜梭菌α毒素基因工程疫苗及其制备方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN114621963A (zh) * 2022-03-11 2022-06-14 牧原食品股份有限公司 一种猪魏氏梭菌a型的亚单位疫苗及其制备

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1483042A (en) * 1974-07-29 1977-08-17 Lapointe J Anti-tumour product of bacterial origin
SU627610A1 (ru) * 1977-09-30 1980-02-05 Zemlyakova V P Препарат землаково в.п. против клюстридиозов животных и птиц
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
ES2185631T3 (es) * 1992-05-20 2003-05-01 Secr Defence Vacunas de clostridium perfringens.
GB9605222D0 (en) 1996-03-12 1996-05-15 Secr Defence Clostridium perfringens epsilon toxin vaccines
DK0892054T3 (da) * 1997-06-20 2007-04-02 Intervet Int Bv Clostridium perfringens-vaccine
RU2129441C1 (ru) * 1997-12-10 1999-04-27 Пирожков Михаил Константинович Вакцина, ассоциированная против анаэробной энтеротоксемии и эшерихиоза поросят
US6399074B1 (en) * 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
AUPQ899700A0 (en) * 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
RU2324498C2 (ru) * 2002-12-09 2008-05-20 Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. Кокцидиальная вакцина и методы ее приготовления и использования
JP2007512006A (ja) * 2003-11-10 2007-05-17 ザ ユーエービー リサーチ ファウンデーション 細菌輸送およびｃｎｓ侵襲を低減させるための組成物およびこの組成物を使用する方法
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine

Also Published As

Publication number Publication date
JP2013255518A (ja) 2013-12-26
RU2011147308A (ru) 2013-05-27
US7732187B2 (en) 2010-06-08
CA2649426A1 (en) 2007-11-01
CO6140037A2 (es) 2010-03-19
ECSP088827A (es) 2008-11-27
AU2007240949B2 (en) 2013-03-14
CN101489584B (zh) 2013-05-01
JP5551933B2 (ja) 2014-07-16
TWI338045B (en) 2011-03-01
US20110008389A1 (en) 2011-01-13
EP2368571A1 (en) 2011-09-28
IL194714A (en) 2015-03-31
WO2007123850A3 (en) 2008-03-06
ES2401810T3 (es) 2013-04-24
AU2007240949A1 (en) 2007-11-01
PE20080167A1 (es) 2008-03-10
BRPI0711572A2 (pt) 2011-11-16
US20100166800A1 (en) 2010-07-01
US7807456B2 (en) 2010-10-05
NZ571970A (en) 2012-02-24
RU2445364C2 (ru) 2012-03-20
US7972604B2 (en) 2011-07-05
UA95951C2 (xx) 2011-09-26
UA109105C2 (uk) 2015-07-27
AR079941A2 (es) 2012-02-29
RU2593945C2 (ru) 2016-08-10
RU2008144913A (ru) 2010-05-27
CA2649426C (en) 2014-04-01
NO20084810L (no) 2009-01-16
HK1125315A1 (en) 2009-08-07
EP2007420A2 (en) 2008-12-31
WO2007123850A2 (en) 2007-11-01
KR20080110908A (ko) 2008-12-19
JP2009533071A (ja) 2009-09-17
MX2008013451A (es) 2008-10-30
AR060471A1 (es) 2008-06-18
IL194714A0 (en) 2011-08-01
TW200801182A (en) 2008-01-01
CN101489584A (zh) 2009-07-22
US20070286874A1 (en) 2007-12-13
PL2007420T3 (pl) 2013-08-30
EP2007420B1 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
ZA200808872B (en) Recombinant attenuated clostridium organisms and vaccine
HK1218427A1 (zh) 改進的疫苗及其使用方法
GB2451014B (en) Engineered Listeria comprising a modified ActA-antigen fusion protein and its use as a vaccine
IL216712A (en) Polypeptides derived from 1depdc
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
ZA200904061B (en) Fuel composition and its use
EP2318429A4 (en) PROMININ-1 PEPTIDE FRAGMENTS AND ITS USE
GB0616306D0 (en) Vaccines
IL196861A0 (en) Antibodies against ccr5 and uses thereof
EP2133416A4 (en) RECOMBINANT MICROORGANISM
GB0615635D0 (en) Immunogenic proteins and uses thereof
IL195525A0 (en) Replikin peptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
EP2049661A4 (en) RECOMBINANT BUTYRYLCHOLINESTERASE WITH LONG HALF-LIFE
GB0818065D0 (en) Immunogenic peptides and uses thereof
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL180839A0 (en) Vaccine comprising recombinant ct or lt toxin
EP2012771A4 (en) VACCINES BASED ON NANOEMULSION
GB0614460D0 (en) Vaccines
IL220146A0 (en) Tmem22 peptides and vaccines including the same
EP1985695A4 (en) RECOMBINANT MICROORGANISM
PL2032708T3 (pl) Rekombinowane nowirabdowirusy i ich zastosowania
EP2196477A4 (en) MODIFIED RECOMBINANT HUMAN ENDOSTATIN AND ITS APPLICATION
EP2061506A4 (en) VACCINE COMPOSITION AND IMMUNIZATION METHOD